Operaciones Baxter International - BAX CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.24 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Baxter International Inc ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 40.67 |
| Abrir* | 40.41 |
| Cambio de 1 año* | -46.81% |
| Rango del día* | 40.27 - 41.16 |
| Rango de 52 semanas | 37.35-76.48 |
| Volumen medio (10 días) | 5.13M |
| Volumen medio (3 meses) | 124.16M |
| Capitalización de mercado | 20.60B |
| Ratio P/E | -100.00K |
| Acciones en circulación | 505.85M |
| Ingresos | 15.06B |
| EPS | -4.89 |
| Dividendo (Rendimiento %) | 2.84872 |
| Beta | 0.57 |
| Próxima fecha de resultados | Jul 26, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | 41.06 | 0.77 | 1.91% | 40.29 | 41.28 | 40.05 |
| May 31, 2023 | 40.64 | 0.73 | 1.83% | 39.91 | 40.86 | 39.72 |
| May 30, 2023 | 40.27 | -0.38 | -0.93% | 40.65 | 41.02 | 40.16 |
| May 26, 2023 | 41.22 | -0.10 | -0.24% | 41.32 | 41.54 | 40.80 |
| May 25, 2023 | 41.28 | -0.07 | -0.17% | 41.35 | 41.49 | 40.76 |
| May 24, 2023 | 42.07 | 0.05 | 0.12% | 42.02 | 42.34 | 41.71 |
| May 23, 2023 | 42.44 | 0.12 | 0.28% | 42.32 | 43.18 | 42.10 |
| May 22, 2023 | 42.52 | -0.21 | -0.49% | 42.73 | 43.07 | 42.37 |
| May 19, 2023 | 42.92 | -0.03 | -0.07% | 42.95 | 43.31 | 42.64 |
| May 18, 2023 | 42.97 | 0.47 | 1.11% | 42.50 | 43.02 | 42.30 |
| May 17, 2023 | 42.72 | 0.06 | 0.14% | 42.66 | 43.16 | 42.42 |
| May 16, 2023 | 42.95 | 0.59 | 1.39% | 42.36 | 43.62 | 42.28 |
| May 15, 2023 | 42.63 | 0.19 | 0.45% | 42.44 | 43.08 | 42.13 |
| May 12, 2023 | 42.41 | -0.69 | -1.60% | 43.10 | 43.45 | 42.19 |
| May 11, 2023 | 43.30 | -0.25 | -0.57% | 43.55 | 43.78 | 42.97 |
| May 10, 2023 | 43.75 | 0.69 | 1.60% | 43.06 | 44.12 | 42.85 |
| May 9, 2023 | 43.04 | -1.81 | -4.04% | 44.85 | 44.85 | 42.31 |
| May 8, 2023 | 45.56 | -0.69 | -1.49% | 46.25 | 47.09 | 44.75 |
| May 5, 2023 | 46.00 | 0.55 | 1.21% | 45.45 | 46.11 | 45.15 |
| May 4, 2023 | 45.24 | -0.75 | -1.63% | 45.99 | 46.30 | 45.16 |
Baxter International Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Thursday, June 8, 2023 | ||
| Hora (UTC) (UTC) 14:00 | País US
| Evento Baxter International Inc at Jefferies Healthcare Conference Baxter International Inc at Jefferies Healthcare ConferenceForecast -Previous - |
| Wednesday, July 26, 2023 | ||
| Hora (UTC) (UTC) 13:30 | País US
| Evento Q2 2023 Baxter International Inc Earnings Release Q2 2023 Baxter International Inc Earnings ReleaseForecast -Previous - |
| Wednesday, October 25, 2023 | ||
| Hora (UTC) (UTC) 12:30 | País US
| Evento Q3 2023 Baxter International Inc Earnings Release Q3 2023 Baxter International Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 15113 | 12784 | 11673 | 11362 | 11099 |
| Ingresos | 15113 | 12784 | 11673 | 11362 | 11099 |
| Coste de los ingresos, total | 9690 | 7626 | 7038 | 6541 | 6305 |
| Beneficio bruto | 5423 | 5158 | 4635 | 4821 | 4794 |
| Gastos totales de explotación | 17207 | 11129 | 10213 | 10345 | 9492 |
| Gastos de venta/general/administración Gastos, total | 3609 | 2619 | 2357 | 2397 | 2387 |
| Investigación y desarrollo | 602 | 529 | 496 | 508 | 599 |
| Gastos (ingresos) extraordinarios | 3306 | 355 | 322 | 899 | 210 |
| Other Operating Expenses, Total | -9 | ||||
| Ingresos de explotación | -2094 | 1655 | 1460 | 1017 | 1607 |
| Ingresos por intereses (gastos), netos No operativos | -400 | -170 | -170 | -124 | -28 |
| Otros, netos | 141 | -8 | 2 | 77 | 38 |
| Ingresos netos antes de impuestos | -2353 | 1477 | 1292 | 970 | 1617 |
| Ingresos netos después de impuestos | -2421 | 1295 | 1110 | 817 | 1345 |
| Beneficio neto antes de partidas extra. Elementos | -2433 | 1284 | 1102 | 807 | 1345 |
| Total de partidas extraordinarias | 0 | 0 | 194 | 201 | |
| Ingresos netos | -2433 | 1284 | 1102 | 1001 | 1546 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -2433 | 1284 | 1102 | 807 | 1345 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -2433 | 1284 | 1102 | 1001 | 1546 |
| Beneficio neto diluido | -2433 | 1284 | 1102 | 1001 | 1546 |
| Promedio ponderado de acciones diluidas | 504 | 508 | 517 | 519 | 546 |
| BPA diluido sin partidas extraordinarias | -4.82738 | 2.52756 | 2.13153 | 1.55491 | 2.46337 |
| Dividends per Share - Common Stock Primary Issue | 1.15 | 1.085 | 0.955 | 0.85 | 0.73 |
| BPA normalizado diluido | 2.10317 | 3.0315 | 2.60928 | 2.84008 | 2.4359 |
| Intereses menores | -12 | -11 | -8 | -10 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 3649 | 3887 | 3773 | 3746 | 3707 |
| Ingresos | 3649 | 3887 | 3773 | 3746 | 3707 |
| Coste de los ingresos, total | 2300 | 2418 | 2626 | 2289 | 2357 |
| Beneficio bruto | 1349 | 1469 | 1147 | 1457 | 1350 |
| Gastos totales de explotación | 3463 | 3696 | 6572 | 3395 | 3544 |
| Gastos de venta/general/administración Gastos, total | 774 | 986 | 782 | 817 | 790 |
| Investigación y desarrollo | 157 | 153 | 148 | 148 | 149 |
| Gastos (ingresos) extraordinarios | 180 | 139 | 2958 | 60 | 153 |
| Ingresos de explotación | 186 | 191 | -2799 | 351 | 163 |
| Ingresos por intereses (gastos), netos No operativos | -126 | -153 | -172 | -66 | -96 |
| Otros, netos | 10 | 186 | 5 | 10 | 27 |
| Ingresos netos antes de impuestos | 70 | 224 | -2966 | 295 | 94 |
| Ingresos netos después de impuestos | 45 | 185 | -2934 | 255 | 73 |
| Intereses menores | -1 | -4 | -3 | -3 | -2 |
| Beneficio neto antes de partidas extra. Elementos | 44 | 181 | -2937 | 252 | 71 |
| Ingresos netos | 44 | 181 | -2937 | 252 | 71 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 44 | 181 | -2937 | 252 | 71 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 44 | 181 | -2937 | 252 | 71 |
| Beneficio neto diluido | 44 | 181 | -2937 | 252 | 71 |
| Promedio ponderado de acciones diluidas | 507 | 507 | 504 | 508 | 509 |
| BPA diluido sin partidas extraordinarias | 0.08679 | 0.357 | -5.82738 | 0.49606 | 0.13949 |
| Dividends per Share - Common Stock Primary Issue | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 |
| BPA normalizado diluido | 0.41026 | 0.50296 | 0.43849 | 0.5315 | 0.62672 |
| Depreciation / Amortization | 52 | 58 | 81 | 95 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 8011 | 8872 | 8411 | 7503 | 5959 |
| Efectivo e inversiones a corto plazo | 1718 | 2951 | 3730 | 3335 | 1838 |
| Efectivo y Equivalentes | 1718 | 2951 | 3730 | 3335 | 1838 |
| Inversiones a corto plazo | |||||
| Total deudores, neto | 2752 | 2713 | 2077 | 1896 | 1840 |
| Accounts Receivable - Trade, Net | 2752 | 2713 | 2077 | 1896 | 1840 |
| Total Inventory | 2718 | 2453 | 1916 | 1653 | 1667 |
| Prepaid Expenses | 424 | 365 | 346 | 230 | 210 |
| Other Current Assets, Total | 399 | 390 | 342 | 389 | 404 |
| Total Assets | 28287 | 33521 | 20019 | 18193 | 15720 |
| Property/Plant/Equipment, Total - Net | 5529 | 5808 | 5325 | 5120 | 4530 |
| Property/Plant/Equipment, Total - Gross | 11971 | 12358 | 11874 | 11268 | 10333 |
| Accumulated Depreciation, Total | -6442 | -6550 | -6549 | -6148 | -5803 |
| Goodwill, Net | 6843 | 9836 | 3217 | 3030 | 3002 |
| Intangibles, Net | 6793 | 7792 | 1671 | 1471 | 1410 |
| Other Long Term Assets, Total | 653 | 835 | 1038 | 762 | 599 |
| Total Current Liabilities | 4745 | 4236 | 3333 | 3230 | 2814 |
| Accounts Payable | 1139 | 1246 | 1043 | 892 | 998 |
| Payable/Accrued | 571 | 638 | 704 | ||
| Accrued Expenses | 1801 | 2087 | 1053 | 961 | 900 |
| Notes Payable/Short Term Debt | 299 | 301 | 0 | 226 | 2 |
| Current Port. of LT Debt/Capital Leases | 1105 | 210 | 406 | 315 | 2 |
| Other Current Liabilities, Total | 401 | 392 | 260 | 198 | 208 |
| Total Liabilities | 22454 | 24444 | 11330 | 10311 | 7876 |
| Total Long Term Debt | 15232 | 17149 | 5786 | 4809 | 3481 |
| Long Term Debt | 15170 | 17081 | 5722 | 4755 | 3481 |
| Deferred Income Tax | 698 | 962 | 143 | 192 | 215 |
| Minority Interest | 62 | 44 | 37 | 30 | 22 |
| Other Liabilities, Total | 1717 | 2053 | 2031 | 2050 | 1344 |
| Total Equity | 5833 | 9077 | 8689 | 7882 | 7844 |
| Common Stock | 683 | 683 | 683 | 683 | 683 |
| Additional Paid-In Capital | 6322 | 6197 | 6043 | 5955 | 5898 |
| Retained Earnings (Accumulated Deficit) | 14050 | 17065 | 16328 | 15718 | 15075 |
| Treasury Stock - Common | -11389 | -11488 | -11051 | -10764 | -9989 |
| Other Equity, Total | -3833 | -3380 | -3314 | -3710 | -3823 |
| Total Liabilities & Shareholders’ Equity | 28287 | 33521 | 20019 | 18193 | 15720 |
| Total Common Shares Outstanding | 504.432 | 501.615 | 504.915 | 506.155 | 512.999 |
| Note Receivable - Long Term | 211 | 224 | 222 | 231 | 176 |
| Long Term Investments | 247 | 154 | 135 | 76 | 44 |
| Capital Lease Obligations | 62 | 68 | 64 | 54 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 8099 | 8011 | 7810 | 7882 | 8173 |
| Efectivo e inversiones a corto plazo | 1673 | 1718 | 1601 | 1852 | 2294 |
| Efectivo y Equivalentes | 1673 | 1718 | 1601 | 1852 | 2294 |
| Total deudores, neto | 2639 | 2659 | 2555 | 2473 | 2471 |
| Accounts Receivable - Trade, Net | 2639 | 2659 | 2555 | 2473 | 2471 |
| Total Inventory | 2922 | 2718 | 2675 | 2663 | 2548 |
| Prepaid Expenses | 861 | 912 | 976 | 890 | 855 |
| Other Current Assets, Total | 4 | 4 | 3 | 4 | 5 |
| Total Assets | 28291 | 28287 | 27965 | 31831 | 32716 |
| Property/Plant/Equipment, Total - Net | 5554 | 5529 | 5345 | 5542 | 5723 |
| Property/Plant/Equipment, Total - Gross | 11622 | 11421 | 11084 | 11504 | 11757 |
| Accumulated Depreciation, Total | -6622 | -6442 | -6285 | -6528 | -6643 |
| Goodwill, Net | 6868 | 6843 | 6639 | 9644 | 9816 |
| Intangibles, Net | 6640 | 6793 | 6927 | 7459 | 7693 |
| Other Long Term Assets, Total | 1011 | 1111 | 1244 | 1304 | 1311 |
| Total Current Liabilities | 4760 | 4745 | 3708 | 3916 | 3890 |
| Accounts Payable | 1290 | 1139 | 1234 | 1282 | 1223 |
| Accrued Expenses | 2157 | 2202 | 2195 | 2226 | 2258 |
| Notes Payable/Short Term Debt | 50 | 299 | 275 | 200 | 200 |
| Current Port. of LT Debt/Capital Leases | 1103 | 1105 | 4 | 208 | 209 |
| Total Liabilities | 22412 | 22454 | 22430 | 22972 | 23641 |
| Total Long Term Debt | 15278 | 15232 | 16153 | 16278 | 16765 |
| Long Term Debt | 15278 | 15232 | 16153 | 16278 | 16765 |
| Minority Interest | 62 | 62 | 44 | 44 | 44 |
| Other Liabilities, Total | 2312 | 2415 | 2525 | 2734 | 2942 |
| Total Equity | 5879 | 5833 | 5535 | 8859 | 9075 |
| Common Stock | 683 | 683 | 683 | 683 | 683 |
| Additional Paid-In Capital | 6312 | 6322 | 6297 | 6253 | 6207 |
| Retained Earnings (Accumulated Deficit) | 13947 | 14050 | 14015 | 17099 | 16994 |
| Treasury Stock - Common | -11324 | -11389 | -11406 | -11409 | -11422 |
| Other Equity, Total | -3739 | -3833 | -4054 | -3767 | -3387 |
| Total Liabilities & Shareholders’ Equity | 28291 | 28287 | 27965 | 31831 | 32716 |
| Total Common Shares Outstanding | 505.836 | 504.432 | 504.044 | 503.807 | 503.437 |
| Note Receivable - Long Term | 119 | ||||
| Other Current Liabilities, Total | 160 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -2421 | 1295 | 1110 | 1011 | 1546 |
| Efectivo de actividades de explotación | 1211 | 2222 | 1868 | 2104 | 2017 |
| Efectivo de actividades de explotación | 1403 | 890 | 823 | 789 | 771 |
| Deferred Taxes | -225 | -146 | -88 | -310 | -263 |
| Partidas no monetarias | 3477 | 344 | 295 | 1039 | 211 |
| Cash Taxes Paid | 330 | 282 | 249 | 294 | 301 |
| Intereses pagados en efectivo | 355 | 145 | 137 | 103 | 94 |
| Cambios en el capital circulante | -1023 | -161 | -272 | -425 | -248 |
| Efectivo de actividades de inversión | -931 | -11200 | -1179 | -1100 | -916 |
| Gastos de capital | -679 | -743 | -709 | -696 | -659 |
| Otras partidas de flujo de caja de inversión, total | -252 | -10457 | -470 | -404 | -257 |
| Efectivo procedente de actividades de financiación | -1438 | 8245 | -345 | 498 | -2603 |
| Elementos de flujo de caja de financiación | -61 | -138 | -52 | -48 | -33 |
| Total Cash Dividends Paid | -573 | -530 | -473 | -423 | -376 |
| Emisión (retiro) de acciones, neto | 95 | -413 | -298 | -914 | -2194 |
| Emisión (amortización) de deuda, neta | -899 | 9326 | 478 | 1883 | 0 |
| Efectos del cambio de divisas | -76 | -47 | 57 | -5 | -63 |
| Variación neta de la tesorería | -1234 | -780 | 401 | 1497 | -1565 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 45 | -2421 | -2606 | 328 | 73 |
| Cash From Operating Activities | 479 | 1211 | 772 | 482 | 208 |
| Cash From Operating Activities | 319 | 1403 | 1069 | 735 | 380 |
| Deferred Taxes | -50 | -225 | -174 | -87 | -55 |
| Non-Cash Items | 35 | 3477 | 3365 | 64 | 34 |
| Changes in Working Capital | 130 | -1023 | -882 | -558 | -224 |
| Cash From Investing Activities | -170 | -931 | -675 | -491 | -304 |
| Capital Expenditures | -172 | -679 | -479 | -311 | -140 |
| Other Investing Cash Flow Items, Total | 2 | -252 | -196 | -180 | -164 |
| Cash From Financing Activities | -372 | -1438 | -1319 | -1017 | -548 |
| Financing Cash Flow Items | -10 | -61 | -51 | -30 | -25 |
| Total Cash Dividends Paid | -146 | -573 | -427 | -281 | -140 |
| Issuance (Retirement) of Stock, Net | 36 | 95 | 82 | 88 | 66 |
| Issuance (Retirement) of Debt, Net | -252 | -899 | -923 | -794 | -449 |
| Foreign Exchange Effects | 18 | -76 | -130 | -74 | -13 |
| Net Change in Cash | -45 | -1234 | -1352 | -1100 | -657 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.9709 | 60554683 | 11083859 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4583 | 27610959 | 452915 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2077 | 21284408 | -212345 | 2023-03-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 3.5746 | 18082159 | 8186853 | 2023-03-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.9578 | 9903377 | 2132589 | 2023-03-31 | HIGH |
| Macquarie Investment Management | Investment Advisor | 1.8235 | 9224199 | 1449983 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7735 | 8971166 | 170213 | 2023-03-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 1.6831 | 8513989 | 8512295 | 2023-03-31 | LOW |
| Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 1.5794 | 7989246 | -17797773 | 2023-03-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4706 | 7439184 | 1748181 | 2022-12-31 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 1.4243 | 7204767 | 114267 | 2023-03-31 | MED |
| State Farm Insurance Companies | Insurance Company | 1.3548 | 6853390 | 0 | 2023-03-31 | LOW |
| Generation Investment Management LLP | Investment Advisor/Hedge Fund | 1.3165 | 6659564 | -4222750 | 2023-03-31 | LOW |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.1821 | 5979786 | 3271267 | 2023-03-31 | HIGH |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 1.1403 | 5768387 | 1338203 | 2023-03-31 | LOW |
| Millennium Management LLC | Hedge Fund | 1.058 | 5351665 | 2242199 | 2023-03-31 | HIGH |
| BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 1.017 | 5144535 | 2302815 | 2023-03-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.0063 | 5090367 | -97615 | 2023-03-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9582 | 4847098 | 636287 | 2023-03-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.9343 | 4726213 | 3483763 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Baxter Company profile
Sobre Baxter International Inc
Baxter International Inc., a través de sus subsidiarias, proporciona productos renales y hospitalarios. La compañía opera a través de dos segmentos: productos hospitalarios y renal. Su negocio de Productos Hospitalarios fabrica soluciones estériles intravenosas y conjuntos de administración, medicamentos premezclados y sistemas de reconstitución de fármacos, viales y jeringas prellenados para medicamentos inyectables, productos de nutrición intravenosas, terapias de nutrición parenteral, bombas de infusión sanguínea, anestésicos inhalatorios y productos de biocirugía. El negocio de Renal ofrece una cartera para satisfacer las necesidades de los pacientes con enfermedad renal en etapa terminal o enfermedad renal irreversible y lesiones renales agudas, incluidas tecnologías y terapias para diálisis peritoneal, hemodiálisis, terapia de reemplazo renal continua y servicios adicionales de diálisis. Sus productos son utilizados por hospitales, centros de diálisis de riñones, hogares de ancianos, centros de rehabilitación, consultorios médicos y por pacientes en el hogar bajo supervisión médica.
El precio actual de la acción Baxter International en tiempo real es 41.18 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Nippon Telegraph and Telephone Corporation, ATN Int, ADTRAN, Inc., Cablevisión Holding S.A., Social Capital Suvretta Holdings Corp. I y Wolfspeed, Inc.. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Df2-1W
One Baxter Pkwy
DEERFIELD
ILLINOIS 60015
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com